Matinas BioPharma Holdings Inc (NYSE American:MTNB)
| 0.4001 Delayed Data As of Jun 02 |  +0.0075 / +1.91%Today’s Change | 0.38 Today|||52-Week Range 0.94 | -19.98% Year-to-Date |
Latest MTNB News | Press Releases
No recent news for Matinas BioPharma Holdings Inc.
Today’s Trading
| Previous close | 0.39 |
| Today’s open | 0.40 |
| Day’s range | 0.39 - 0.41 |
| Volume | 245,964 |
| Average volume (3 months) | 400,894 |
| Market cap | $86.6M |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | +14.11% |
| Earnings growth (this year) | -16.07% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +9,464.10% |
| P/E ratio | NM |
| Price/Sales | 34.00 |
| Price/Book | 2.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SLGLSol Gel Technologies... | -0.02 | -0.44% |
| RVLPRVL Pharmaceuticals ... | -0.06 | -6.82% |
| SPHDFSanthera Pharmaceuti... | 0.00 | 0.00% |
| DAREDare Bioscience Inc | 0.00 | 0.00% |
Data as of 3:57pm ET, 06/02/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $3.2M |
| Annual profit (last year) | -$21.0M |
| Net profit margin | -658.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bedminster, New Jersey |
Forecasts
